We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ARTV market cap is 130.68M. The company's latest EPS is USD -1.1824 and P/E is -4.55.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|
| USD ($) | |||
| Total Revenue | 251k | 0 | 0 |
| Operating Income | -14.49M | -16.19M | -18.33M |
| Net Income | -13.96M | -17.84M | -17.47M |
| Year End December 30 2023 | 2023 |
|---|---|
| USD ($) | |
| Total Revenue | 33.49M |
| Operating Income | -30.67M |
| Net Income | -28.72M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|
| USD ($) | |||
| Total Assets | 90.16M | 75.91M | 225.6M |
| Total Liabilities | 48.42M | 50.6M | 24.6M |
| Total Equity | -174.67M | -191.1M | 201M |
| Year End December 30 2023 | 2023 |
|---|---|
| USD ($) | |
| Total Assets | 105.11M |
| Total Liabilities | 50.72M |
| Total Equity | -162.02M |
| Market Cap | 130.68M |
| Price to Earnings Ratio | -4.55 |
| Price to Sales Ratio | 3.9 |
| Price to Cash Ratio | 2.44 |
| Price to Book Ratio | 2.4 |
| Dividend Yield | - |
| Shares Outstanding | 24.29M |
| Average Volume (1 week) | 56.36k |
| Average Volume (1 Month) | 68.41k |
| 52 Week Change | -66.38% |
| 52 Week High | 17.31 |
| 52 Week Low | 5.01 |
| Spread (Intraday) | 3.3 (52.38%) |
| Company Name | Artiva Biotherapeutics Inc |
| Address |
838 walker rd, suite 21-2 dover, delaware 19904 |
| Website | https://www.artivabio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
